Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

MLN-4924

Home/Tag:MLN-4924
16 12, 2010

Attention Long Term Revlimid Users: Millennium Pharmaceuticals Working To Develop A New Anti-Leukemia Drug, MLN 4924.

Tags: , , , , |0 Comments

Last week I wrote several articles about the results from two new studies, both finding an 8% risk of developing a secondary cancer in patients who use Revlimid over an extended period of time.At the end of one of the articles I stated:My opinion is this:It seems to me an 8% risk of developing another manageable

19 10, 2009

Are Myeloma Blogs Becoming Too Technical?

Tags: , , |3 Comments

Cancer blogs and Websites run the gambit from highly emotional personal stories to highly technical reviews of drug trials and scientific studies. Multiple myeloma sites are no different. After my initial diagnosis, I soon became frustrated by the lack of technical information available in books or on the Internet. That is why I wrote my

19 10, 2009

MLN-4924 & MLN-9708

Tags: , , |0 Comments

Here are two more drugs that are expected to "work better" or "be better" than Velcade. I first wrote about both of these last July. Both are going to be manufactured by the same company, Millennium, that makes Velcade. MLN-4924. A new drug in Phase I trials that has shown encouraging results in pre-clinical trials

24 07, 2009

Let’s Get Technical!

Tags: , , , |0 Comments

OK. Enough emotional stuff! Let's get to the exciting techno breakthrough stuff guaranteed to give myeloma patients a different type of hope; the scientific kind. MLN-4924. A new drug in Phase I trials that has shown encouraging results in pre-clinical trials against both hematologic and solid tumors. MLN-9708. Also in Phase I trials. Researchers at